Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Organization
Trials
Phase 2, Recruiting, 100 people, May 20, 2026
A Prolonged Nightly Fasting for Men on ADT for PCa
Completed, 40 people, Mar 10, 2026
Collaborator, Phase 2, Recruiting, 496 people, Aug 1, 2025
Phase 1/2, Recruiting, 400 people, Feb 14, 2025
Collaborator, Phase 1/2, Recruiting, 109 people, Oct 4, 2024
Collaborator, Phase 2, Recruiting, 34 people, Feb 15, 2024
Penn Medicine Biobank Return of Results Program
Collaborator, Active, not recruiting, 2,500 people, Oct 19, 2023
Phase 1, Completed, 6 people, Oct 3, 2022
Phase 1, Terminated, 4 people, Sep 10, 2022
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Phase 3, Recruiting, 660 people, Jul 22, 2022
Two Step Haplo With Radiation Conditioning
Phase 2, Recruiting, 63 people, Sep 2, 2021
Phase 2, Active, not recruiting, 50 people, Jul 7, 2020
Phase 1/2, Withdrawn, 0 people, Jun 5, 2020
Phase 2, Status unknown, 66 people, Apr 27, 2020
Phase 1, Completed, 8 people, Feb 25, 2020
Phase 4, Status unknown, 76 people, Dec 19, 2019
Phase 1, Completed, 4 people, Dec 10, 2019
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Phase 2, Active, not recruiting, 150 people, Jan 8, 2019
Phase 2, Completed, 10 people, Oct 19, 2018
Early phase 1, Completed, 38 people, Aug 7, 2018
Sources: clinicaltrials.gov